Works matching IS 10837159 AND DT 2021 AND VI 26 AND IP 3
Results: 36
Homeopathic Treatment as an Add‐On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non‐Small Cell Lung Cancer: A Prospective, Randomized, Placebo‐Controlled, Double‐Blind, Three‐Arm, Multicenter Study
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Management of Abemaciclib‐Associated Adverse Events in Patients with Hormone Receptor‐Positive, Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Redefining the Treatment Endpoints in Oncology.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e521, doi. 10.1002/onco.13688
- By:
- Publication type:
- Article
EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 242, doi. 10.1002/onco.13685
- By:
- Publication type:
- Article
First‐in‐Class Selective HDAC6 Inhibitor (ACY‐1215) Has a Highly Favorable Safety Profile in Patients with Relapsed and Refractory Lymphoma.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 184, doi. 10.1002/onco.13673
- By:
- Publication type:
- Article
In Reply: Randomized Studies Are Needed to Improve Knowledge of Nutritional Interventions for Advanced Cancer Patients.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e519, doi. 10.1002/onco.13672
- By:
- Publication type:
- Article
Supplemental Parenteral Nutrition in Patients with Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e518, doi. 10.1002/onco.13671
- By:
- Publication type:
- Article
Impact of Home Parenteral Nutrition on Quality of Life in Cancer Patients: Don't Throw the Baby Out With the Bath Water.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e516, doi. 10.1002/onco.13670
- By:
- Publication type:
- Article
Heterogeneity in Quality of Life of Long‐Term Colon Cancer Survivors: A Latent Class Analysis of the Population‐Based PROFILES Registry.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e492, doi. 10.1002/onco.13655
- By:
- Publication type:
- Article
Utility of the Geriatric 8 for the Prediction of Therapy‐Related Toxicity in Older Adults with Diffuse Large B‐Cell Lymphoma.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 215, doi. 10.1002/onco.13641
- By:
- Publication type:
- Article
A Randomized Phase II Study of AGS‐16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 182, doi. 10.1002/onco.13628
- By:
- Publication type:
- Article
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e414, doi. 10.1002/onco.13623
- By:
- Publication type:
- Article
Through the Virtual Looking Glass.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 261, doi. 10.1002/onco.13621
- By:
- Publication type:
- Article
An Illustrative Case of Combination Cabozantinib/Nivolumab for Progressive Metastatic Renal Cell Carcinoma (mRCC).
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e508, doi. 10.1002/onco.13617
- By:
- Publication type:
- Article
Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 250, doi. 10.1002/onco.13616
- By:
- Publication type:
- Article
Apatinib in Combination with S‐1 as First‐Line Treatment in Patients with Advanced Metastatic Gastric Cancer: Results from an Open, Exploratory, Single‐Arm, Phase II Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e374, doi. 10.1002/onco.13613
- By:
- Publication type:
- Article
A Multicenter Analysis of Immune Checkpoint Inhibitors as Adjuvant Therapy Following Treatment of Isolated Brain Metastasis.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e505, doi. 10.1002/onco.13608
- By:
- Publication type:
- Article
Wild‐type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 208, doi. 10.1002/onco.13607
- By:
- Publication type:
- Article
SARS‐CoV‐2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e500, doi. 10.1002/onco.13602
- By:
- Publication type:
- Article
Molecular Profiling of Exceptional Responders to Cancer Therapy.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 186, doi. 10.1002/onco.13600
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e394, doi. 10.1002/onco.13597
- By:
- Publication type:
- Article
The Impact of Human Papillomavirus Infection on Skin Cancer: A Population‐Based Cohort Study.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e473, doi. 10.1002/onco.13593
- By:
- Publication type:
- Article
2020 Innovation‐Based Optimism for Lung Cancer Outcomes.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e454, doi. 10.1002/onco.13590
- By:
- Publication type:
- Article
A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e367, doi. 10.1002/onco.13582
- By:
- Publication type:
- Article
Emerging Immunotherapies in the Treatment of Brain Metastases.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 231, doi. 10.1002/onco.13575
- By:
- Publication type:
- Article
Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e382, doi. 10.1002/onco.13574
- By:
- Publication type:
- Article
Do Patients Regret Having Received Systemic Treatment for Advanced Non‐Small Cell Lung Cancer: A Prospective Evaluation.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 224, doi. 10.1002/onco.13571
- By:
- Publication type:
- Article
Providing Supportive and Palliative Care Using Telemedicine for Patients with Advanced Cancer During the COVID‐19 Pandemic in Mexico.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e512, doi. 10.1002/onco.13568
- By:
- Publication type:
- Article
FDA Supplemental Approval Summary: Lenvatinib for the Treatment of Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e484, doi. 10.1002/onco.13566
- By:
- Publication type:
- Article
Impact of Primary Tumor Location on Survival After Curative Resection in Patients with Colon Cancer: A Meta‐Analysis of Propensity Score‐Matching Studies.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 196, doi. 10.1002/onco.13555
- By:
- Publication type:
- Article
Acquired MET D1228N Mutations Mediate Crizotinib Resistance in Lung Adenocarcinoma with ROS1 Fusion: A Case Report.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 178, doi. 10.1002/onco.13545
- By:
- Publication type:
- Article
Myocardial Ischemia Induced by 5‐Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e403, doi. 10.1002/onco.13536
- By:
- Publication type:
- Article
Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e445, doi. 10.1002/onco.13535
- By:
- Publication type:
- Article
Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e425, doi. 10.1002/onco.13533
- By:
- Publication type:
- Article
Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3‐TACC3 Fusion and Recurrent Glioblastoma.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 173, doi. 10.1002/onco.13530
- By:
- Publication type:
- Article
Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non‐Small Cell Lung Cancer in CALGB 9730 (Alliance A151729).
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e435, doi. 10.1002/onco.13527
- By:
- Publication type:
- Article